Natera, Inc.
NTRA • NASDAQ
Natera, Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Steven Leonard Chapman, with a market cap of $25.9B.
CEOSteven Leonard Chapman
Next Earnings
Upcoming earnings announcement for Natera, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.56
Revenue Estimate
$616.7M
Earnings History
Past 12 earnings reports for Natera, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Q4 2025 | $0.36Est: -$0.50 | +172.0% | $665.5MEst: $624.6M | +6.6% | — |
| Nov 6, 2025 | Q3 2025 | -$0.64Est: -$0.37 | -73.0% | $592.2MEst: $513.5M | +15.3% |  10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.74Est: -$0.60 | -23.3% | $546.6MEst: $475.1M | +15.0% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.50Est: -$0.66 | +24.2% | $501.8MEst: $446.7M | +12.3% | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$0.41Est: -$0.39 | -5.1% | $476.1MEst: $428.5M | +11.1% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.26Est: -$0.57 | +54.4% | $439.8MEst: $361.5M | +21.7% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.30Est: -$0.69 | +56.5% | $413.4MEst: $342.3M | +20.7% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.56Est: -$0.70 | +20.0% | $367.7MEst: $316.3M | +16.3% | 10-Q |
| Feb 28, 2024 | Q4 2023 | -$0.65Est: -$0.73 | +11.0% | $311.1MEst: $285.6M | +8.9% | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.95Est: -$0.95 | 0.0% | $268.3MEst: $259.1M | +3.6% | — |
| Aug 3, 2023 | Q2 2023 | -$0.97Est: -$1.09 | +11.0% | $261.4MEst: $242.1M | +8.0% | 10-Q |
| May 9, 2023 | Q1 2023 | -$1.23Est: -$1.15 | -7.0% | $241.8MEst: $228.5M | +5.8% | 10-Q |